eNGINEERING HUMAN RESILIENCE IN EXTREME ENVIRONMENTS
Astraea Technologies
Validating Healthcare Where Failure Is Not an Option
Astraea Technologies is an Australian deep-technology company safeguarding human health and performance in extreme environments.
As human activity pushes deeper into extreme environments, the systems we depend on—pharmaceuticals, medical devices, and life-support technologies—are already being used beyond their validated design limits.
Most have never been properly tested under these conditions.
When it matters most, will they still work?
Astraea exists to answer that question with evidence.
The Problem
A growing validation gap
Across critical sectors, human life depends on healthcare systems and technology operating beyond validated conditions:
-
In space, ionising radiation degrades pharmaceuticals over time
-
In defence and disaster zones, medical supplies face extreme stress without validation, pushing shelf life limits and risking lives
-
In nuclear medicine, products are exposed to radiation beyond standard testing regimes
Yet, no formal consideration has been given to developing healthcare systems and technologies to survive these extreme environments.
Failure is no longer an edge case, it is a system-level risk.
the solution
Replacing assumptions with evidence
Astraea builds validation-to-insight systems that quantify how extreme environmental stressors impact human-critical technologies.
We test, measure, and model how systems behave under real-world conditions, before deployment.
Our approach:
-
Test — Controlled exposure to mission-relevant stressors
-
Analyse — Degradation pathways and dose-response profiling
-
Optimise — Engineering and formulation improvements
-
Deploy — Systems validated for real-world performance
This enables earlier decision-making, reduced uncertainty, and higher confidence in deployment.
our business model
Testing-as-a-Service with compounding data advantage
Validation Services
Contract-based testing, degradation analysis, and dose-response profiling
Advisory & Optimisation
Reformulation guidance, certification pathways, and regulatory strategy
Data & Research Partnerships
Collaborative programs that generate proprietary, compounding datasets over time
astraea drift, enabled by hiro-lab
Astraea’s platform brings together two integrated capabilities that transform how healthcare systems are validated for extreme environments.
Astraea DRIFT
An analytical intelligence layer that transforms complex datasets into structured, decision-ready insight, revealing how systems degrade and when failure begins.
HIRO-LAB
A modular validation engine that generates high-fidelity exposure and degradation data under ionising radiation and extreme environmental conditions.
Together, they form a unified validation-to-insight system; bridging physical testing with predictive understanding, and turning environmental risk into measurable, actionable data.
Sector Solutions
One system. Multiple high-risk environments.
Astraea is building an integrated validation-to-intelligence platform, HIRO-LAB + Astraea DRIFT, for sectors where failure has greater consequences and performance is non-negotiable.
From space to healthcare, defence to disaster response, we generate the evidence that defines how critical systems behave under extreme conditions.
Space and Aerospace
Validating pharmaceuticals and life-support systems under cosmic radiation, isolation, and constrained resupply for long-duration missions.
Healthcare and Nuclear Medicine
Ensuring medical devices and pharmaceuticals perform reliably in radiological environments beyond conventional lab conditions.
Defence and Security
Human-support technologies built to perform in austere, high-risk environments where failure and field replacement are not options.
Disaster Response and Remote Operations
Pre-validating critical products for disaster zones and remote environments where resupply is impossible and worst-case conditions are reality.
Our work sits at the intersection of healthcare, materials science, systems engineering, and deep-tech analytics—supporting safer missions, stronger products, and more resilient human operations.
CEO - Brooke Mills
Astraea origins
Inspired by Astraea, the ancient symbol of justice, integrity, and moral clarity, Astraea Technologies was founded on a simple but urgent belief:
As humanity moves into harsher, more unforgiving environments, the systems that protect human life must be held to a higher standard.
Modern pharmaceuticals and medical technologies are rigorously tested for terrestrial use, but rarely validated against the compounded stressors of extreme environments, both on Earth and beyond.
Astraea exists to close that gap.
founding team
Astraea was founded by engineers, scientists, and communicators focused on one question:
How do we ensure human-critical technologies remain reliable in environments where failure is not an option?
Together, the team combines technical depth, systems thinking, and communication capability, forming the foundation for Astraea’s work in building a new category of infrastructure for extreme environments.
Co-Founder and Chief Executive Officer
Brooke Mills
Brooke is a seasoned startup leader with over 20 years’ experience in technology, innovation, and growth ‑stage organisations. She leads strategy, partnerships, fundraising, and execution, ensuring Astraea delivers long‑term impact and global relevance.
Co-Founder and Chief Technology Officer
Gordon Carroll
Gordi brings deep expertise across space systems, neuroscience, and human‑centred engineering. He leads Astraea’s technical strategy, platform development, and scientific integrity, driving the company’s mission to enable safe human operations in extreme environments.
Marketing and Communications Manager
Graeme Kuchmar
Graeme is a strategic storyteller with a passion for space, technology, and innovation, bridging complex technical ideas into clear, compelling narratives that connect Astraea’s mission to industry, partners, and the broader public.
Traction and Milestones
Dec 2024
Company founded (Sydney)
Brooke, Gordi (NSW) and Graeme (VIC) join forces
2025
Outreach
CEO engagement with ESA, ANSTO, Paris Air Show
Sep 2025
IAC 2025
HIRO-LAB presented at IAC 2025
2026
Testing begins
Earth-based validation and testing due to begin
Late 2026
First orbital payload
First HIRO-LAB launch to ISS altitude forecast
Astraea featured in Wholesale Investor
Astraea is featured in Wholesale Investor interview "Dying for a cure" for tackling how radiation impacts the effectiveness of pharmaceuticals and medical systems in extreme environments.
.png)
First test payload launch in 2026
Astraea Technologies signs an EOI to launch its first HIRO-LAB payload to 400 km with Sunburnt Space, targeting a late 2026 mission.
One year and accelerating
Astraea celebrates its 1-year anniversary, highlighting major milestones including IAC 2025, global industry engagement, and early validation of HIRO-LAB.
IAC 2025 Media Release
Astraea Technologies Debuts HIRO-LAB concept at International Astronautical Congress (IAC) 2025.
IAC 2025 Paper
Astraea presents its research on how heavy ionising radiation impacts pharmaceutical stability in space environments.
news & resources
±5%
Goal radiation mapping precision margain
2.0%
Pharmaceutical degradation sensitivity
10K
Unique data points over 30-day deployment
$5M
Customer savings vs. independent study
<3kg
Projected payload mass - compact & cost efficient
100%
Open data policy for collaborative research partners
Concept illustration only
HIRO-LAB
The Heavy Ionising Radiation Observation Laboratory (HIRO‑LAB) is Astraea’s inaugural analytical platform. Originally conceived to address one of space exploration’s most overlooked risks—the degradation of medicines under cosmic radiation—HIRO‑LAB has been deliberately designed as a modular, extensible system applicable across multiple industries.
.png)